U.S. drugmaker Pernix Therapeutics explores sale: Reuters
Pernix Therapeutics Holdings Inc (PTX.O), a U.S. specialty pharmaceutical company, is exploring strategic alternatives, including a potential sale, Reuters News reported.
9 February 2016•2 mins read
